Lexeo Therapeutics (LXEO) Other Non Operating Income: 2022-2024
Historic Other Non Operating Income for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to -$9,000.
- Lexeo Therapeutics' Other Non Operating Income was N/A to -$7,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$13,000, marking a year-over-year change of. This contributed to the annual value of -$9,000 for FY2024, which is 30.77% up from last year.
- Latest data reveals that Lexeo Therapeutics reported Other Non Operating Income of -$9,000 as of FY2024, which was up 30.77% from -$13,000 recorded in FY2023.
- Lexeo Therapeutics' 5-year Other Non Operating Income high stood at -$2,000 for FY2022, and its period low was -$13,000 during FY2023.
- Its 3-year average for Other Non Operating Income is -$8,000, with a median of -$9,000 in 2024.
- As far as peak fluctuations go, Lexeo Therapeutics' Other Non Operating Income plummeted by 550.00% in 2023, and later spiked by 30.77% in 2024.
- Over the past 3 years, Lexeo Therapeutics' Other Non Operating Income (Yearly) stood at -$2,000 in 2022, then slumped by 550.00% to -$13,000 in 2023, then skyrocketed by 30.77% to -$9,000 in 2024.